WHO ICTRP trial
Long-term co-administration study of OPC-262 in patients with type 2 diabetes…
JPRN-jRCT2080221215 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080221215 |
|---|---|
| Public title | Long-term co-administration study of OPC-262 in patients with type 2 diabetes mellitus |
| Scientific title | Long-term co-administration study of OPC-262 in patients with type 2 diabetes mellitus |
| Primary sponsor | Otsuka Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | type 2 diabetes |
| Interventions | investigational material(s) Generic name etc : OPC-262 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : orally once daily |
| Registration date | Aug 20, 2010 |
| Secondary IDs | JapicCTI-101252 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: